Keynote Financial Services LLC Purchases 11,863 Shares of Celularity Inc. (NASDAQ:CELU)

Keynote Financial Services LLC boosted its position in shares of Celularity Inc. (NASDAQ:CELU) by 90.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,023 shares of the company’s stock after acquiring an additional 11,863 shares during the quarter. Keynote Financial Services LLC’s holdings in Celularity were worth $52,000 at the end of the most recent quarter.

Celularity Price Performance

Shares of Celularity stock opened at $1.16 on Friday. The company’s fifty day simple moving average is $2.09 and its two-hundred day simple moving average is $2.42. Celularity Inc. has a 12-month low of $1.15 and a 12-month high of $7.97.

Celularity (NASDAQ:CELU) last posted its earnings results on Friday, December 6th. The company reported ($0.73) earnings per share (EPS) for the quarter. Celularity had a negative return on equity of 119.53% and a negative net margin of 72.72%.

Celularity Company Profile

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.